CN113607534B - 一种染色方法、试剂盒及应用 - Google Patents
一种染色方法、试剂盒及应用 Download PDFInfo
- Publication number
- CN113607534B CN113607534B CN202110963181.8A CN202110963181A CN113607534B CN 113607534 B CN113607534 B CN 113607534B CN 202110963181 A CN202110963181 A CN 202110963181A CN 113607534 B CN113607534 B CN 113607534B
- Authority
- CN
- China
- Prior art keywords
- staining
- solution
- cell
- washing
- penetrating agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000004043 dyeing Methods 0.000 title claims abstract description 24
- 238000010186 staining Methods 0.000 claims abstract description 111
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 99
- 230000000149 penetrating effect Effects 0.000 claims abstract description 86
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 83
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 70
- 102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 claims abstract description 42
- 101000733249 Homo sapiens Tumor suppressor ARF Proteins 0.000 claims abstract description 41
- 229960000583 acetic acid Drugs 0.000 claims abstract description 35
- 239000012362 glacial acetic acid Substances 0.000 claims abstract description 35
- 238000003365 immunocytochemistry Methods 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 252
- 210000004027 cell Anatomy 0.000 claims description 238
- 239000000243 solution Substances 0.000 claims description 224
- 238000005406 washing Methods 0.000 claims description 126
- 238000004140 cleaning Methods 0.000 claims description 86
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 claims description 54
- 239000012192 staining solution Substances 0.000 claims description 44
- 102000004190 Enzymes Human genes 0.000 claims description 39
- 108090000790 Enzymes Proteins 0.000 claims description 39
- 229940088598 enzyme Drugs 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 238000012760 immunocytochemical staining Methods 0.000 claims description 36
- 239000007788 liquid Substances 0.000 claims description 33
- MPVDXIMFBOLMNW-ISLYRVAYSA-N 7-hydroxy-8-[(E)-phenyldiazenyl]naphthalene-1,3-disulfonic acid Chemical compound OC1=CC=C2C=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C2=C1\N=N\C1=CC=CC=C1 MPVDXIMFBOLMNW-ISLYRVAYSA-N 0.000 claims description 28
- 239000003153 chemical reaction reagent Substances 0.000 claims description 28
- 238000011534 incubation Methods 0.000 claims description 27
- 102000003992 Peroxidases Human genes 0.000 claims description 25
- 230000007935 neutral effect Effects 0.000 claims description 25
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 25
- 210000004085 squamous epithelial cell Anatomy 0.000 claims description 24
- 230000002496 gastric effect Effects 0.000 claims description 18
- 239000008191 permeabilizing agent Substances 0.000 claims description 16
- 238000007789 sealing Methods 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 14
- 238000007447 staining method Methods 0.000 claims description 13
- 108010019160 Pancreatin Proteins 0.000 claims description 11
- 239000002981 blocking agent Substances 0.000 claims description 11
- 238000011161 development Methods 0.000 claims description 11
- 239000000834 fixative Substances 0.000 claims description 11
- 229940055695 pancreatin Drugs 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 6
- 241000283707 Capra Species 0.000 claims description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims description 3
- 239000003593 chromogenic compound Substances 0.000 claims description 3
- 239000000565 sealant Substances 0.000 claims description 2
- 238000004040 coloring Methods 0.000 abstract description 4
- 230000000877 morphologic effect Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 235000019441 ethanol Nutrition 0.000 description 72
- 238000002791 soaking Methods 0.000 description 56
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 28
- 239000010410 layer Substances 0.000 description 27
- 239000008096 xylene Substances 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 20
- 239000000758 substrate Substances 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 15
- 239000000427 antigen Substances 0.000 description 13
- 108091007433 antigens Proteins 0.000 description 13
- 102000036639 antigens Human genes 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 210000000805 cytoplasm Anatomy 0.000 description 11
- 238000003745 diagnosis Methods 0.000 description 11
- 230000008439 repair process Effects 0.000 description 11
- 206010008342 Cervix carcinoma Diseases 0.000 description 10
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 201000010881 cervical cancer Diseases 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
- 230000003902 lesion Effects 0.000 description 9
- 210000003097 mucus Anatomy 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 230000008823 permeabilization Effects 0.000 description 8
- 239000006059 cover glass Substances 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 206010008263 Cervical dysplasia Diseases 0.000 description 4
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 210000000601 blood cell Anatomy 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000001574 biopsy Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000003855 cell nucleus Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 230000003780 keratinization Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000000633 nuclear envelope Anatomy 0.000 description 3
- 108091008819 oncoproteins Proteins 0.000 description 3
- 102000027450 oncoproteins Human genes 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 2
- 108010077544 Chromatin Proteins 0.000 description 2
- 208000009608 Papillomavirus Infections Diseases 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 230000002380 cytological effect Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 2
- 230000002055 immunohistochemical effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 239000000439 tumor marker Substances 0.000 description 2
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 244000208060 Lawsonia inermis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108050002653 Retinoblastoma protein Proteins 0.000 description 1
- 241000872198 Serjania polyphylla Species 0.000 description 1
- 108700025695 Suppressor Genes Proteins 0.000 description 1
- 241000224526 Trichomonas Species 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002573 colposcopy Methods 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000009841 epithelial lesion Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000013115 immunohistochemical detection Methods 0.000 description 1
- 238000012151 immunohistochemical method Methods 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000012716 precipitator Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N1/31—Apparatus therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110963181.8A CN113607534B (zh) | 2021-08-20 | 2021-08-20 | 一种染色方法、试剂盒及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110963181.8A CN113607534B (zh) | 2021-08-20 | 2021-08-20 | 一种染色方法、试剂盒及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113607534A CN113607534A (zh) | 2021-11-05 |
CN113607534B true CN113607534B (zh) | 2022-10-18 |
Family
ID=78341554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110963181.8A Active CN113607534B (zh) | 2021-08-20 | 2021-08-20 | 一种染色方法、试剂盒及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113607534B (zh) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997016731A1 (en) * | 1995-11-02 | 1997-05-09 | Thomas Jefferson University | Immunocytochemical staining of exfoliated cervical samples |
CN1920559A (zh) * | 2005-08-24 | 2007-02-28 | 赵翀 | 一种细胞生物技术、试剂盒及制备装置 |
WO2011091438A1 (en) * | 2010-01-25 | 2011-07-28 | George Mason Intellectual Properties, Inc. | Improved one-step cell and tissue preservative for morphologic and molecular analysis |
CN103033409B (zh) * | 2011-10-09 | 2015-08-19 | 安徽新标志科技有限公司 | 改进的组织细胞染色方法及其应用 |
CN104007257B (zh) * | 2013-02-24 | 2017-02-08 | 北京莱尔生物医药科技有限公司 | 一种检测非体液性稀有有核细胞的方法和试剂盒 |
CN107202888B (zh) * | 2017-07-11 | 2018-10-12 | 广州江元医疗科技有限公司 | 一种用于宫颈液基细胞的p16INK4a免疫标记显色试剂盒 |
CN109425527B (zh) * | 2017-09-04 | 2021-10-01 | 艾托金生物医药(苏州)有限公司 | 一种细胞染色方法 |
CN107677827A (zh) * | 2017-10-09 | 2018-02-09 | 亚能生物技术(深圳)有限公司 | 一种宫颈癌辅助分级诊断的双染试剂盒及其应用 |
CA3083599A1 (en) * | 2017-12-06 | 2019-06-13 | Genentech, Inc. | Synthetic controls for immunohistochemistry |
CN109239030A (zh) * | 2018-08-10 | 2019-01-18 | 北京莱尔生物医药科技有限公司 | 一种检测循环肿瘤细胞her2不同位点和er、pr的试剂盒及应用 |
-
2021
- 2021-08-20 CN CN202110963181.8A patent/CN113607534B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN113607534A (zh) | 2021-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3377530B1 (en) | Methods of identifying immune cells in pd-l1 positive tumor tissue | |
CN107202888B (zh) | 一种用于宫颈液基细胞的p16INK4a免疫标记显色试剂盒 | |
CN106053806A (zh) | 一种hpv免疫胶体金诊断试纸条及其制备方法和检测方法 | |
US20240011099A1 (en) | Stained biological specimens including one or more biomarkers labeled with one or more detectable moieties | |
US7838215B2 (en) | Advanced cervical cell screening methods | |
CN114113616B (zh) | 一种试剂盒及其染色方法 | |
CN104745670A (zh) | 一种细胞芯片的制备方法及其在肿瘤筛查领域的应用 | |
CN109425527B (zh) | 一种细胞染色方法 | |
CN113607534B (zh) | 一种染色方法、试剂盒及应用 | |
EP2773390B1 (en) | Methods and compositions for preparing samples for immunostaining | |
CN111551720A (zh) | 一种检测ogn蛋白表达的方法及其在胃癌辅助诊断中的应用 | |
CN111363789B (zh) | 一种同时检测蛋白质和rna的试剂盒和方法 | |
CN116381240A (zh) | 一种双染免疫组化试剂盒及应用 | |
US9182403B2 (en) | Kits for and methods of differential staining of cervical cancer cells and/or tissues | |
RU2419798C1 (ru) | Способ иммуногистохимического окрашивания криостатных срезов тканей в условиях интраоперационной диагностики | |
CN113567677B (zh) | 一种免疫荧光信号放大技术标记方法 | |
Mabruk et al. | A rapid microwave‐in situ hybridization method for the definitive diagnosis of oral hairy leukoplakia: comparison with immunohistochemistry | |
WO2016174185A1 (en) | Multiplex immunohistochemical panel for the identification of metastatic carcinoma in cytology fluid specimens | |
CN115074342B (zh) | 一种抗人酸性磷酸酶单克隆抗体及其应用 | |
CN112362874B (zh) | 一种宫颈癌筛查试剂盒 | |
CN116068189A (zh) | 早期癌检测试剂及其应用 | |
WO2017061152A1 (ja) | 子宮頸がんの試験方法およびそれに用いる試験試薬 | |
US20240043904A1 (en) | Morphological marker staining | |
CN110095605B (zh) | 一种肺癌的筛查试剂盒 | |
CN118169388A (zh) | 用于检测P16和Ki-67蛋白的双重免疫荧光染色方法及试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Xing Yanan Inventor after: Niu Yinyin Inventor after: Mi Guanxun Inventor after: Zhao Linlin Inventor after: Zhang Linzi Inventor after: Li Sanhua Inventor after: Liu Wendi Inventor after: Qi Hua Inventor after: Liu Chang Inventor before: Xing Yanan Inventor before: Niu Yinyin Inventor before: Mi Guanxun Inventor before: Zhao Linlin Inventor before: Zhang Linzi Inventor before: Li Sanhua Inventor before: Liu Wendi Inventor before: Qi Hua Inventor before: Liu Chang |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Xing Yanan Inventor after: Li Sanhua Inventor after: Mi Guanxun Inventor after: Zhao Linlin Inventor after: Zhang Linzi Inventor after: Niu Yinyin Inventor after: Liu Wendi Inventor after: Qi Hua Inventor after: Liu Chang Inventor before: Xing Yanan Inventor before: Niu Yinyin Inventor before: Mi Guanxun Inventor before: Zhao Linlin Inventor before: Zhang Linzi Inventor before: Li Sanhua Inventor before: Liu Wendi Inventor before: Qi Hua Inventor before: Liu Chang |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |